← Eichor
Condition: Withdrawal Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Withdrawal

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Optimizing Treatment for Patients With Juvenile Idiopathic Arthritis in Sustained Remission: The MOVE-JIA Trial
Phase 4 · 7 location(s) · Oslo University Hospital · NCT06653634REgulatory T Cell Therapy to Achieve Immunosuppression REduction
Phase 2 · 7 location(s) · Singulera Therapeutics Inc. · NCT06552169Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia
Phase 3 · 20 location(s) · Neurocrine Biosciences · NCT07227818Randomized Withdrawal Study in Patients With Schizophrenia
Phase 3 · 22 location(s) · Vanda Pharmaceuticals · NCT06961968Evaluation of the Effect of Cordycepin on CD8+ Lymphocytopenia in Patients With Solid Tumors
Phase 2 · 1 location(s) · Second Affiliated Hospital of Soochow University · NCT07258160Sparrow Link Neuromodulation Device for Opioid Withdrawal Management in Hospitalized Adults With Opioid Use Disorder
NA · 1 location(s) · Payel Roy · NCT07079826Impact of Cocaine Use and Withdrawal on Sleep
Phase N/A · 3 location(s) · Hôpital le Vinatier · NCT07119567Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
Phase 3 · 51 location(s) · Axsome Therapeutics, Inc. · NCT07398417Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3
Phase 3 · 6 location(s) · Emory University · NCT05834478Can Connected Devices Increase the Success Rate of Benzodiazepine Withdrawals in the Elderly?
NA · 1 location(s) · University Hospital, Toulouse · NCT04912479Added Value of 18 FDG Pet-scanner in Diagnosis and Management of Subclinical Rejection in Kidney Transplant Patients
NA · 1 location(s) · University of Liege · NCT04702022Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Phase 2/Phase 3 · 118 location(s) · Janssen Research & Development, LLC · NCT05327114Novel Use of Probenecid to Alleviate Symptoms of Opioid Withdrawal
Phase 2 · 1 location(s) · University of Calgary · NCT04939623Effects of Cannabidiol on Stress and Nicotine Withdrawal
Phase 1 · 1 location(s) · Johns Hopkins University · NCT07001930Vaping and Smoking Withdrawal Project
NA · 1 location(s) · State University of New York at Buffalo · NCT05772845Evaluating Buspirone to Treat Opioid Withdrawal
Phase 2 · 1 location(s) · University of Maryland, Baltimore · NCT05511909StrAtegies For Zoledronic Acid Post-dEnosumab Discontinuation in Postmenopausal oSTeoporosis
Phase 4 · 17 location(s) · University Hospital, Toulouse · NCT06767150Impact of the Mandibular Advancement Device on Sleep Apnea During CPAP Withdrawal
NA · 1 location(s) · University Hospital, Angers · NCT05939934Assessing a Clinically-meaningful Opioid Withdrawal Phenotype
Phase 2 · 1 location(s) · University of Maryland, Baltimore · NCT05027919Cannabis, Linked Emotions, and Adolescent Risk Study
NA · 1 location(s) · Massachusetts General Hospital · NCT06576076Effects of Ketone Supplementation on Alcohol Withdrawal and Brain Metabolism in Alcohol Use Disorder
Phase 2/Phase 3 · 1 location(s) · University of Pennsylvania · NCT06559995Early Withdrawal Exposure and Negative Affect Withdrawal (NAW) Regulation Training for Smoking Cessation
Phase 3 · 1 location(s) · University of Alabama at Birmingham · NCT03912194IWS Diagnosis Criteria Consensus
Phase N/A · 1 location(s) · ELIAS Emergency University Hospital · NCT07316894CEDRN: Opioid Registry
Phase N/A · 1 location(s) · University of British Columbia · NCT07466784Effect of Chest Tube Withdrawal on Patients' Anxiety Levels After Thoracic Surgery
Phase N/A · 1 location(s) · Ankara Ataturk Sanatorium Training and Research Hospital · NCT06531928Exploration of Mechanisms for Weaning Failure
Phase N/A · 1 location(s) · The First Affiliated Hospital of Guangzhou Medical Universit · NCT06424314Understanding the Effects of Transcutaneous Auricular Neurostimulation for Treatment of Chronic Pain
NA · 1 location(s) · The University of Texas Medical Branch, Galveston · NCT05555485A Study to Train a Machine Learning Algorithm for an Evaluation of the Use of Biometric Data Captured at the Wrist for t
NA · 4 location(s) · OpiAID · NCT07405398Bright Light Therapy During Residential Alcohol Withdrawal
NA · 1 location(s) · Centre Hospitalier St Anne · NCT06878287Validation of the French Version of the Prediction of the Alcohol Withdrawal Severity Scale (PAWSS)
Phase N/A · 1 location(s) · Etablissement Public de Santé Barthélemy Durand · NCT06675539
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.